Health Condition 1: E039- Hypothyroidism, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Willing to give consent to participate in the study. 2. Patients in age group between 30-60 years of either sex. 3. Patients positive for Zulewskiââ?¬•s clinical score for hypothyroidism. 4. Patient fulfilling the laboratory diagnosis of hypothyroidism on the basis of serum TSH, T3 and T4 levels. 5. Patients having uncontrolled TSH level in spite adequate doses of Levothyroxine.
Exclusion criteria
Exclusion criteria: 1. Patients age 60 years. 2. Patients with ischemic heart disease, uncontrolled hypertension, myocardial infarction, cerebrovascular event, cardiac arrhythmias, pregnancy and active malignant disease were excluded from the study. 3. Patients with altered thyroid hormone levels due to other conditions such as undernutrition, malignant neoplasm or non-thyroidal illness (low-T3 syndrome).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Thyroid profile 2.Lipid profile 3.Complete blood countTimepoint: Before drug trail and after drug trail i.e.,after 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Agni assessmentTimepoint: Three month before and after trail;WHO QOL BreifTimepoint: Three month before and after trail | — |
Countries
India
Contacts
Banaras Hindu University